CPC A61K 35/74 (2013.01) [A61P 3/04 (2018.01); A61P 3/06 (2018.01); C12N 1/205 (2021.05); A23L 33/135 (2016.08); A61K 8/99 (2013.01)] | 1 Claim |
1. A method for treating metabolic syndrome in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of at least one isolated bacterium belonging to the genus Dysosmobacter, wherein the nucleotide sequence of the 16S rRNA gene of said isolated bacterium has at least 98% identity with SEQ ID NO: 1.
|